Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_assertion type Assertion NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_head.
- NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_assertion wasGeneratedBy ECO_0000203 NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_provenance.
- NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_assertion wasDerivedFrom befree-20140225 NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_provenance.
- NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_assertion SIO_000772 11303727 NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_provenance.
- NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_assertion evidence source_evidence_literature NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_provenance.
- NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_assertion description "[The PSGL-1 inhibitor did significantly decrease local neutrophil infiltration and bacterial clearance in the peritoneum following CLP, but this did not increase the systemic levels of proinflammatory cytokines, the quantitative levels of bacteremia, or the overall mortality rate following CLP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882920.RAfJubuCim3J0um4wmC302G7iBHfyAqglrQIb2VQ_aWUE130_provenance.